A phase III, randomized, double-blind, controlled trial of carboxyamidotriazole plus chemotherapy for the treatment of advanced non-small cell lung cancer

Xiaoyan Si, Li Zhang, Ying Cheng et al.|Therapeutic Advances in Medical Oncology|2020

Cited by 15